Gradual recovery; valuations comfortable Solara Active Pharma’s (Solara) Q2FY23 performa...
On track for course correction Work in progress to better outlook of Vizag facility * Solar...
Solara Active Pharma Sciences is currently trading at Rs. 415.00, up by 17.35 points or 4.36% fro...
Recovering business provides respite Solara Active Pharma (Solara) has reported better-than-es...
Washed-out quarter; blurred outlook Solara Active Pharma’s (Solara) Q3FY22 performance w...
Destocking of Ibuprofen; Auroure merger delayed. Solara Active Pharma (Solara) reported Q2FY22...
Working on multiple fronts to enhance business prospects We recently met with the management o...
Q1 miss; outlook intact Solara Active Pharma (Solara) reported Q1FY22 performance was below es...
Buy Solara Active Pharma Ltd For Target Rs.2,050 Solara 2.0 to target faster growth * Backw...
Larsen & Toubro Infotech Limited * On the weekly chart, the stock has witnessed 6-8 months...
Strong growth continues Solara Active Pharma (Solara) reported strong growth in Q4FY21 led by ...
‘Partner of Choice’ in API/CRAMS space * Solara Active Pharma Sciences (SOLARA) ha...
The company reported standalone net profit of Rs 57.15 crore for the quarter ended March 31, 2021...